REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA

REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA was reported 102 times

REFRACTORY CYTOPENIA WITH MULTILINEAGE DYSPLASIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 SLAMF7-directed Immunostimulatory Antibody [EPC] 2 0.0004
1 Histone Deacetylase Inhibitor [EPC] 1 0.0003
2 Alkylating Drug [EPC] 48 0.0002
3 Topoisomerase Inhibitor [EPC] 15 0.0002
4 Proteasome Inhibitor [EPC] 15 0.0001
5 Purine Antimetabolite [EPC] 7 0.0001
6 Thrombopoietin Receptor Agonist [EPC] 1 0.0001
7 Thalidomide Analog [EPC] 33 0.0001
8 Nucleoside Metabolic Inhibitor [EPC] 15 0.0001
9 CD20-directed Cytolytic Antibody [EPC] 17 0.0001
10 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1 0.0000
11 Iron Chelator [EPC] 1 0.0000
12 Corticosteroid [EPC] 43 0.0000
13 Oxazolidinone Antibacterial [EPC] 1 0.0000
14 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
15 Platinum-based Drug [EPC] 8 0.0000
16 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000
17 Aldosterone Antagonist [EPC] 3 0.0000
18 Folate Analog Metabolic Inhibitor [EPC] 8 0.0000
19 BCL-2 Inhibitor [EPC] 1 0.0000
20 Glycopeptide Antibacterial [EPC] 1 0.0000
21 Leukocyte Growth Factor [EPC] 2 0.0000
22 Osmotic Laxative [EPC] 3 0.0000
23 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
24 Sulfonylurea [EPC] 1 0.0000
25 HMG-CoA Reductase Inhibitor [EPC] 3 0.0000
26 Azole Antifungal [EPC] 1 0.0000
27 Janus Kinase Inhibitor [EPC] 1 0.0000
28 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
29 Platelet Aggregation Inhibitor [EPC] 3 0.0000
30 Retinoid [EPC] 1 0.0000
31 Opioid Agonist [EPC] 1 0.0000
32 Kinase Inhibitor [EPC] 2 0.0000
33 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
34 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
35 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
36 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
37 Loop Diuretic [EPC] 1 0.0000
38 Proton Pump Inhibitor [EPC] 1 0.0000